US Stock MarketDetailed Quotes

BCLI Brainstorm Cell Therapeutics

Watchlist
  • 1.740
  • +0.120+7.41%
Close Nov 27 16:00 ET
  • 1.680
  • -0.060-3.45%
Post 19:46 ET
9.92MMarket Cap-504P/E (TTM)

Brainstorm Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-49.49%3.05M
-45.27%2.98M
-51.97%2.47M
-13.63%21.44M
-2.26%4.8M
-11.78%6.04M
-28.22%5.45M
-5.92%5.15M
1.15%24.82M
-20.88%4.92M
Selling and administrative expenses
-25.95%2M
-22.41%2.06M
-32.06%1.51M
-1.59%10.69M
26.06%3.11M
-11.75%2.71M
7.14%2.66M
-22.11%2.23M
16.79%10.87M
-2.80%2.46M
-General and administrative expense
-25.95%2M
-22.41%2.06M
-32.06%1.51M
-1.59%10.69M
26.06%3.11M
-11.75%2.71M
7.14%2.66M
-22.11%2.23M
16.79%10.87M
-2.80%2.46M
Research and development costs
-68.62%1.05M
-67.00%922K
-67.13%961K
-23.00%10.75M
-30.72%1.7M
-11.81%3.33M
-45.35%2.79M
11.77%2.92M
-8.40%13.96M
-33.34%2.45M
Operating profit
49.49%-3.05M
45.27%-2.98M
51.97%-2.47M
13.63%-21.44M
2.26%-4.8M
11.78%-6.04M
28.22%-5.45M
5.92%-5.15M
-1.15%-24.82M
20.88%-4.92M
Net non-operating interest income expense
55.37%-54K
-75.00%30K
-85.87%13K
-182.02%-447K
-422.33%-538K
-611.76%-121K
-78.18%120K
-20.00%92K
564.63%545K
-568.18%-103K
Non-operating interest income
----
-75.00%30K
-85.87%13K
----
----
----
--120K
-20.00%92K
----
----
Total other finance cost
-55.37%54K
----
----
182.02%447K
422.33%538K
611.76%121K
----
----
---545K
--103K
Other net income (expense)
-92.01%394K
411K
-940K
4.69M
-236K
4.93M
Gain on sale of security
-92.01%394K
--411K
---940K
--4.69M
---236K
--4.93M
----
----
----
----
Income before tax
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
29.18%-17.19M
-11.16%-5.58M
82.12%-1.23M
24.31%-5.33M
5.62%-5.06M
0.74%-24.28M
18.93%-5.02M
Income tax
Net income
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
29.18%-17.19M
-11.16%-5.58M
82.12%-1.23M
24.31%-5.33M
5.62%-5.06M
0.74%-24.28M
18.93%-5.02M
Net income continuous Operations
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
29.18%-17.19M
-11.16%-5.58M
82.12%-1.23M
24.31%-5.33M
5.62%-5.06M
0.74%-24.28M
18.93%-5.02M
Minority interest income
Net income attributable to the parent company
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
29.18%-17.19M
-11.16%-5.58M
82.12%-1.23M
24.31%-5.33M
5.62%-5.06M
0.74%-24.28M
18.93%-5.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-120.88%-2.71M
52.32%-2.54M
32.77%-3.4M
29.18%-17.19M
-11.16%-5.58M
82.12%-1.23M
24.31%-5.33M
5.62%-5.06M
0.74%-24.28M
18.93%-5.02M
Basic earnings per share
-13.33%-0.51
69.23%-0.6
64.29%-0.75
39.39%-6
15.38%-1.65
84.21%-0.45
31.58%-1.95
6.67%-2.1
2.94%-9.9
23.53%-1.95
Diluted earnings per share
-13.33%-0.51
69.23%-0.6
64.29%-0.75
39.39%-6
15.38%-1.65
84.21%-0.45
31.58%-1.95
6.67%-2.1
2.94%-9.9
23.53%-1.95
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -49.49%3.05M-45.27%2.98M-51.97%2.47M-13.63%21.44M-2.26%4.8M-11.78%6.04M-28.22%5.45M-5.92%5.15M1.15%24.82M-20.88%4.92M
Selling and administrative expenses -25.95%2M-22.41%2.06M-32.06%1.51M-1.59%10.69M26.06%3.11M-11.75%2.71M7.14%2.66M-22.11%2.23M16.79%10.87M-2.80%2.46M
-General and administrative expense -25.95%2M-22.41%2.06M-32.06%1.51M-1.59%10.69M26.06%3.11M-11.75%2.71M7.14%2.66M-22.11%2.23M16.79%10.87M-2.80%2.46M
Research and development costs -68.62%1.05M-67.00%922K-67.13%961K-23.00%10.75M-30.72%1.7M-11.81%3.33M-45.35%2.79M11.77%2.92M-8.40%13.96M-33.34%2.45M
Operating profit 49.49%-3.05M45.27%-2.98M51.97%-2.47M13.63%-21.44M2.26%-4.8M11.78%-6.04M28.22%-5.45M5.92%-5.15M-1.15%-24.82M20.88%-4.92M
Net non-operating interest income expense 55.37%-54K-75.00%30K-85.87%13K-182.02%-447K-422.33%-538K-611.76%-121K-78.18%120K-20.00%92K564.63%545K-568.18%-103K
Non-operating interest income -----75.00%30K-85.87%13K--------------120K-20.00%92K--------
Total other finance cost -55.37%54K--------182.02%447K422.33%538K611.76%121K-----------545K--103K
Other net income (expense) -92.01%394K411K-940K4.69M-236K4.93M
Gain on sale of security -92.01%394K--411K---940K--4.69M---236K--4.93M----------------
Income before tax -120.88%-2.71M52.32%-2.54M32.77%-3.4M29.18%-17.19M-11.16%-5.58M82.12%-1.23M24.31%-5.33M5.62%-5.06M0.74%-24.28M18.93%-5.02M
Income tax
Net income -120.88%-2.71M52.32%-2.54M32.77%-3.4M29.18%-17.19M-11.16%-5.58M82.12%-1.23M24.31%-5.33M5.62%-5.06M0.74%-24.28M18.93%-5.02M
Net income continuous Operations -120.88%-2.71M52.32%-2.54M32.77%-3.4M29.18%-17.19M-11.16%-5.58M82.12%-1.23M24.31%-5.33M5.62%-5.06M0.74%-24.28M18.93%-5.02M
Minority interest income
Net income attributable to the parent company -120.88%-2.71M52.32%-2.54M32.77%-3.4M29.18%-17.19M-11.16%-5.58M82.12%-1.23M24.31%-5.33M5.62%-5.06M0.74%-24.28M18.93%-5.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -120.88%-2.71M52.32%-2.54M32.77%-3.4M29.18%-17.19M-11.16%-5.58M82.12%-1.23M24.31%-5.33M5.62%-5.06M0.74%-24.28M18.93%-5.02M
Basic earnings per share -13.33%-0.5169.23%-0.664.29%-0.7539.39%-615.38%-1.6584.21%-0.4531.58%-1.956.67%-2.12.94%-9.923.53%-1.95
Diluted earnings per share -13.33%-0.5169.23%-0.664.29%-0.7539.39%-615.38%-1.6584.21%-0.4531.58%-1.956.67%-2.12.94%-9.923.53%-1.95
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data